MANE
Veradermics, Incorporated
116.80$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| – | -68.3% | +711.9% | +161.2% | +107.2% | |
| – | -66.3% | +714.9% | +160.4% | +107.7% | |
| – | -89.3% | +284.6% | +673.7% | +89.6% | |
| – | -71.5% | +837.1% | +175.5% | +109.8% | |
| – | -10.3% | +1.7% | +31.6% | – | |
| – | +2,333.5% | +138.3% | -97.5% | +80.5% | |
| – | +20.7% | +60.7% | -26.6% | +74.1% | |
| – | -11.7% | +7.1% | -49.6% | +452.8% | |
| – | -275.6% | – | – | +107.6% | |
| – | – | – | – | – | |
| – | -82.6% | +6.5% | +0.0% | +8.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.